Background Restenosis remains a significant problem in endovascular therapy for
hemodialysis vascular access. Drug-coated balloon (DCB) angioplasty decreases …

Purpose: A late increased mortality risk has been reported in a summary level meta-analysis
of patients with femoropopliteal artery occlusive disease treated with paclitaxel-coated …

Background Standard percutaneous transluminal angioplasty is the current recommended
treatment for dysfunctional hemodialysis fistulas, yet long-term outcomes of this treatment …

Intimal hyperplasia (IH), a crucial histopathological injury, forms the basis of vascular
stenosis and thrombogenesis. In addition, it is common in maladies such as stenosis at the …

Purpose: To report the risk of all-cause mortality after treatment with paclitaxel-coated
devices vs uncoated controls in patients with chronic limb-threatening ischemia (CLTI) …

Importance Hemodialysis requires reliable vascular access to the patient's blood circulation,
such as an arteriovenous access in the form of an autogenous arteriovenous fistula or …

Objective To report the mid-term results of a single-center randomized controlled trial
comparing drug-coated balloon angioplasty (DBA) and plain balloon angioplasty (PBA) for …

Purpose To assess whether angioplasty of hemodialysis access (HA) stenosis with a drug-
coated balloon (DCB) would prevent restenosis in comparison with plain-balloon …

Methods An electronic search was performed on PubMed and EMBASE to identify relevant
randomized controlled trials (RCTs) comparing DCBs and plain balloon angioplasty from …

Objective To perform an individual patient data level meta-analysis of randomised controlled
trials comparing drug coated balloon angioplasty (DCB) against conventional percutaneous …